Trihexyphenidylum [Inn-Latin] en es it fr

Trihexyphenidylum [Inn-Latin] Brand names, Trihexyphenidylum [Inn-Latin] Analogs

Trihexyphenidylum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Trihexyphenidylum [Inn-Latin] Chemical_Formula


Trihexyphenidylum [Inn-Latin] RX_link

Trihexyphenidylum [Inn-Latin] fda sheet

Trihexyphenidylum_[Inn-Latin] FDA

Trihexyphenidylum [Inn-Latin] msds (material safety sheet)

Trihexyphenidylum [Inn-Latin] Synthesis Reference

No information avaliable

Trihexyphenidylum [Inn-Latin] Molecular Weight

301.466 g/mol

Trihexyphenidylum [Inn-Latin] Melting Point

258.5 oC

Trihexyphenidylum [Inn-Latin] H2O Solubility

No information avaliable

Trihexyphenidylum [Inn-Latin] State


Trihexyphenidylum [Inn-Latin] LogP


Trihexyphenidylum [Inn-Latin] Dosage Forms

Tablet; Liquid (oral)

Trihexyphenidylum [Inn-Latin] Indication

Indicated for the treatment of parkinson's disease and extrapyramidal reactions caused by drugs.

Trihexyphenidylum [Inn-Latin] Pharmacology

Trihexyphenidyl is an anticholinergic used in the symptomatic treatment of all etiologic groups of parkinsonism and drug induced extrapyramidal reactions (except tardive dyskinesia). Trihexyphenidyl possesses both anticholinergic and antihistaminic effects, although only the former has been established as therapeutically significant in the management of parkinsonism.

Trihexyphenidylum [Inn-Latin] Absorption

Trihexyphenidyl is rapidly absorbed from the gastrointestinal tract.

Trihexyphenidylum [Inn-Latin] side effects and Toxicity

No information avaliable

Trihexyphenidylum [Inn-Latin] Patient Information

No information avaliable

Trihexyphenidylum [Inn-Latin] Organisms Affected

Humans and other mammals